IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells
収録刊行物
-
- Brain, Behavior, and Immunity
-
Brain, Behavior, and Immunity 25 (6), 1170-1181, 2011-08
Elsevier BV